Clinical Development of BRAF plus MEK Inhibitor Combinations
Author:
Funder
Novartis Pharmaceuticals Corporation
American Society of Clinical Oncology
European Society for Medical Oncology
Publisher
Elsevier BV
Subject
Cancer Research,Oncology
Reference104 articles.
1. BRAF and RAS mutations in human lung cancer and melanoma;Brose;Cancer Res.,2002
2. BRAF(V600) mutations in solid tumors, other than metastatic melanoma and papillary thyroid cancer, or multiple myeloma: a screening study;Cohn;Onco Targets Ther.,2017
3. Mutations of the BRAF gene in human cancer;Davies;Nature,2002
4. Extracellular-regulated kinases: signaling from Ras to ERK substrates to control biological outcomes;Eblen;Adv. Cancer Res.,2018
5. BRAF mutations: signaling, epidemiology, and clinical experience in multiple malignancies;Hall;Cancer Control,2014
Cited by 206 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Role of mitochondria and potential of mitochondria-targeted therapy in BRAF mutant cancer: A review;Critical Reviews in Oncology/Hematology;2024-11
2. MAZ promotes thyroid cancer progression by driving transcriptional reprogram and enhancing ERK1/2 activation;Cancer Letters;2024-10
3. Analysis of BRAF Gene Mutation in Hashimoto’s Thyroiditis With Multifocal Papillary Thyroid Carcinoma;The American Surgeon™;2024-09-09
4. Encorafenib plus binimetinib for BRAF V600E-mutant metastatic NSCLC: clinical implications of the phase 2 PHAROS study;Future Oncology;2024-09-03
5. Pharmacogenomic discovery of genetically targeted cancer therapies optimized against clinical outcomes;npj Precision Oncology;2024-08-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3